CLINICAL_TRIALS
trial_result
· 2020-04-21
Clinical Trial Update: L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels [Phase 2]
Summary
Phase 2 clinical trial evaluating L-arginine in severe asthma patients, analyzed by exhaled nitric oxide levels; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nicholas Kenyon | Conditions: Asthma, Inflammation | Phase 2 | Status: COMPLETED | Results posted: 2020-04-21